Table 1.
Clinical data | Group 1 (n=25) | Group 2 (n=25) | P |
---|---|---|---|
Age | 45±12 | 63±15 | 0.37 |
Male | 16 (64%) | 11 (44%) | 0.13 |
Female | 9 (36%) | 14 (56%) | 0.13 |
Smoker | 6 (24%) | 7 (28%) | 0.71 |
Alcohol consumption | 0 (0%) | 0 (0%) | NS |
Arterial hypertension | 5 (20%) | 11 (44%) | 0.41 |
Coronary heart disease | 0 (0%) | 2 (8%) | 0.15 |
Pulmonary embolism | 0 (0%) | 1 (4%) | 0.31 |
Diabetes mellitus type 2 | 0 (0%) | 5 (20%) | 0.16 |
Peripheral arterial disease | 0 (0%) | 2 (8%) | 0.15 |
Hypercholesterinemia | 0 (0%) | 2 (8%) | 0.15 |
Chronic obstructive pulmonary disease | 0 (0%) | 4 (16%) | 0.34 |
β-blocker therapy | 10 (0%) | 7 (28%) | 0.29 |
Ace-inhibitor therapy | 11 (0%) | 5 (20%) | 0.29 |
Calcium antagonist therapy | 0 (0%) | 2 (8%) | 0.15 |